$LFWD News

Last published 4w ago

4w agoLFWDLifeward’s ReWalk® Personal Exoskeleton Demonstrates Sustained Long-Term Home Use and Patient Satisfaction in Latest Independent Peer-Reviewed StudyGlobeNewswireStudy shows ReWalk can be used for years and provides measurable walking performance for people with chronic paraplegia ReWalk was used for a median of 33 months, with no reported falls or exoskeleton-related fractures
1mo agoLFWDPeer-Reviewed Study of Lifeward’s ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and PainGlobeNewswireLandmark independent study reports significantly improved task performance and satisfaction and lower pain compared with wheelchair use ReWalk users with chronic spinal cord injury were able to perform everyday
2mo agoLFWDLifeward Publishes Updated Investor Presentation Highlighting Commercial Growth StrategyGlobeNewswireHUDSON, Mass. and YOKNEAM ILLIT, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio of
2mo agoLFWDLifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial OfficerGlobeNewswireHUDSON, Mass. and YOKNEAM ILLIT, Israel, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio of
2mo agoNNDM ORMP DRTS LFWDNano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation CommitteeGlobeNewswireWALTHAM, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano," or the "Company") today announced the appointment of Nadav Kidron to its Board of
2mo agoLFWDLifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives GrowthGlobeNewswireRevenue increase and operating performance improve as capital-efficient distribution strategy gains momentum Strengthened balance sheet and expanding rehabilitation platform support continued commercial execution
3mo agoLFWDLifeward to Report Second Quarter 2026 Financial Results on August 14, 2026GlobeNewswireHUDSON, Mass. and YOKNEAM ILLIT, Israel, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio of
3mo agoLFWDLifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal ExoskeletonGlobeNewswireOttobock Care, one of the leading mobility technology patient care organizations in the U.S., brings extensive clinical expertise and patient care infrastructure Advances Lifeward’s strategy to broaden ReWalk access
3mo agoNNDM LFWDNano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the BoardGlobeNewswireWALTHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") today announced the appointment of Moshe Rozenbaum as Interim
4mo agoLFWD ORMPLifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic FinancingGlobeNewswireHUDSON, Mass. and YOKNEAM ILLIT, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio of
5mo agoLFWDLifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed PlatformGlobeNewswireVeteran physician, medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience, mobility technologies, and metabolic disease Promotion reflects
6mo agoLFWDLifeward Reports First Quarter 2026 Financial ResultsGlobeNewswireOramed strategic transaction successfully closed and $10 million financing received Oratech acquisition brings $6.5 million in cash and promising Protein Oral Delivery™ biomed technology, with lead asset
6mo agoLFWDLifeward to Report First Quarter 2026 Financial Results on May 15, 2026GlobeNewswireHUDSON, Mass. and YOKNEAM ILLIT, Israel, May 11, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio of commercialized
6mo agoLFWDLifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered ExoskeletonGlobeNewswireGlobal data since 2013 show just 3% lifetime fracture prevalence, declining to 0.3% over the past six years Zero fractures reported across 97 German users since 2018, spanning broad patient profiles and bone health
7mo agoLFWD ORMPLifeward Successfully Closes on Strategic Partnership with OramedGlobeNewswireHUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of
8mo agoLFWD ORMPLifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical CompanyGlobeNewswirePositions Lifeward as a diversified biomedical innovation company with clear path to profitability Integration of Oramed's POD™ oral delivery technology expands Lifeward into biotech markets while Oramed funds
8mo agoLFWDLifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026GlobeNewswireMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of
8mo agoLFWDLifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal ExoskeletonGlobeNewswireClinic days offered at Shirley Ryan AbilityLab, the #1 ranked rehabilitation hospital for 35 consecutive years, with the goal of accelerating personal exoskeleton adoption Streamlined pathway from evaluation to
8mo agoLFWDLifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke SurvivorsGlobeNewswireIP and technology acquisition is expected to be highly accretive and to advance Lifeward's position as a diversified biomedical innovation companyWill Expand Lifeward's portfolio beyond lower-limb solutions, creating a
8mo agoLFWDLifeward Announces Reverse Share SplitGlobeNewswireHUDSON, Mass. and YOKNEAM ILLIT, Israel, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology designed to transform the lives of
8mo agoLFWDLifeward's ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage InsurersGlobeNewswireAetna joins Humana and United Healthcare in providing Medicare Advantage coverage for beneficiaries who meet medical necessity criteria for the ReWalk Personal Exoskeleton Together, these three national Medicare
10mo agoLFWD ORMPLifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation CompanyGlobeNewswirePositions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential Up to $47 million strategic investment from Oramed and another investor is intended to provide
10mo agoORMP LFWDOramed and Lifeward Announce Strategic TransactionPR NewswireOramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) ("Oramed") and Lifeward Ltd. (NASDAQ: LFWD) ("Lifeward") today announced the signing of...
10mo agoLFWDLifeward Appoints Bob Marshall as Chairman of the BoardGlobeNewswireMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology designed to transform the
10mo agoLFWDLifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab EmiratesGlobeNewswireDistribution agreement with Singapore-based Verita Neuro will provide patients the ReWalk Personal Exoskeleton as part of its multi-layered treatment modalities New delivery model for ReWalk will integrate in-patient
11mo agoLFWDLifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization ApprovalGlobeNewswireHumana and UnitedHealthcare, which granted authorization in November, are the two largest Medicare Advantage providers in the U.S., accounting for 47% of all Medicare Advantage enrollees This latest approval will help
11mo agoLFWDUnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal ExoskeletonGlobeNewswireMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of
12mo agoLFWDLifeward Ltd. Reports Third Quarter 2025 Financial ResultsGlobeNewswireRecord quarter of ReWalk systems placed for Medicare beneficiaries since fee schedule established Ongoing efficiency initiatives drive 16% year-over-year decrease in quarterly cash burn and 27% decrease in quarterly
1y agoLFWDLifeward to Report Third Quarter Financial Results on November 14, 2025GlobeNewswireMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of
1y agoLFWDFirst Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal ExoskeletonGlobeNewswireMedicare Advantage claim processed in less than thirty days Additional progress with traditional Medicare claim approvals has accelerated timelines to payment in 2025 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Sept.
1y agoLFWDLifeward Achieves CE Mark Approval for the ReWalk 7 Personal ExoskeletonGlobeNewswireMARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of people
1y agoLFWDLifeward Ltd. (LFWD) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
1y agoLFWDLifeward Ltd. Reports Second Quarter 2025 Financial ResultsGlobeNewswireAchieves record number of ReWalk systems placed for Medicare beneficiaries since fee schedule established Third consecutive quarter of U.S. ReWalk pipeline growth with over 130 qualified leads in process Appoints new
1y agoLFWDLifeward Names Almog Adar as New CFO, Strengthening Executive LeadershipGlobeNewswireMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of
1y agoLFWDLifeward to Report Second Quarter Financial Results on August 14, 2025GlobeNewswireMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of
1y agoLFWDLifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council RegionGlobeNewswireMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of
1y agoLFWDMedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial ExpansionPR NewswireMedRhythms, Inc., a company pioneering the development of next-generation neurotherapeutics to improve walking, mobility and related functional...
1y agoLFWDLifeward Announces Closing of $2.6 Million Public OfferingGlobeNewswireMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 26, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of
1y agoLFWDLifeward Announces Pricing of $2.6 Million Public OﬀeringGlobeNewswireMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of
1y agoLFWDAdministrative Law Judge Determines ReWalk Personal Exoskeleton is "Reasonable and Necessary" for Medicare BeneficiaryGlobeNewswireMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 24, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of
1y agoLFWDLifeward Names Mark Grant as New CEOGlobeNewswireMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of
1y agoLFWDLifeward to Present at Sidoti Virtual Investor Conference on May 21GlobeNewswireMARLBOROUGH, Mass., and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Lifeward, Ltd., (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of
1y agoLFWDLifeward Ltd. Reports First Quarter 2025 Financial ResultsGlobeNewswireU.S. pipeline of ReWalk opportunities continues to build with over 120 qualified leads in process Closure of AlterG sites and resulting consolidation of resources and reduced expenditures yields improved operating
1y agoLFWDLifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and ExoskeletonsGlobeNewswireMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of
1y agoLFWDLifeward to Report First Quarter 2025 Financial Results on May 15, 2025GlobeNewswireMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of
1y agoLFWDFirst Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal ExoskeletonGlobeNewswireApproval signals important progress in U.S. market expansion as major commercial health insurers begin to follow precedent set with Medicare reimbursement for personal exoskeletons established in 2024 Decision to
1y agoLFWDParalyzed Israeli Soldier Walks Again with Use of the ReWalk Personal ExoskeletonGlobeNewswireMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 24, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of
1y agoLFWDLifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. MarketGlobeNewswireMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 15, 2025 (GLOBE NEWSWIRE) -- Seventh generation of industry-leading personal exoskeleton is now available nationwide for individuals with spinal cord injury New and
1y agoLFWDFDA Issues Clearance for ReWalk 7 ExoskeletonGlobeNewswireMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of
1y agoLFWDLifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial ResultsGlobeNewswireRecord quarterly and annual revenue of $7.5M and $25.7M, respectively Continued strong growth in U.S. pipeline of ReWalk opportunities with over 110 qualified leads in process Strategic shift towards profitability: